Daniel Vitt
Chief Executive Officer at IMMUNIC, INC.
Net worth: 467 327 $ as of 2024-05-30
Network origin in Daniel Vitt first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Julius-Maximilians-Universität Würzburg
23
| College/University | Other Consumer Services | 23 |
22
| Public Company | Biotechnology | 22 |
| Unknown | 20 | ||
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Vitt via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
DSM NV
 DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Chemicals: Specialty | Public Communications Contact Public Communications Contact | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KOENIG & BAUER AG | Industrial Machinery | Director/Board Member Director/Board Member | |
Santo Holding (Deutschland) GmbH
 Santo Holding (Deutschland) GmbH Financial ConglomeratesFinance Santo Holding (Deutschland) GmbH operates as an investment holding company with focus on drug discovery and development. The company is based in Holzkirchen, Germany. | Financial Conglomerates | Chief Executive Officer | |
| MEDIGENE AG | Biotechnology | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Graduate Degree Masters Business Admin | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Investor | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal | |
G2M Cancer Drugs AG
 G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Part of Valerio Therapeutics SA, G2M Cancer Drugs AG is a German company that researches new anti-cancer therapeutics and develops selected late-stage products. The company is based in Frankfurt am Main, Germany. G2M Cancer Drugs was acquired by Topotarget A/S on March 01, 2005. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Technische Universität München | College/University | Undergraduate Degree Undergraduate Degree | |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Director/Board Member Corporate Officer/Principal | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Mannheim | College/University | Undergraduate Degree Masters Business Admin | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
| Technische Universität Braunschweig | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Graduate Degree | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Chief Executive Officer | |
AiCuris GmbH & Co. KG
 AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Jossa Arznei GmbH
 Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Concentro Management AG
 Concentro Management AG Investment ManagersFinance Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program. | Investment Managers | Chairman Director/Board Member | |
| LSP Services Deutschland GmbH | Investment Managers | Private Equity Investor Private Equity Investor | |
| Max Planck Institute of Biochemistry | College/University | Doctorate Degree Doctorate Degree | |
Santo Service GmbH
 Santo Service GmbH Real Estate DevelopmentFinance Santo Service GmbH offers construction and management services for real estate. It holds interest in advising and financial management services. The company was founded on September 19, 2007 and is headquartered in Munich, Germany. | Real Estate Development | Chief Executive Officer | |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
Fund+
 Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
Minaris Regenerative Medicine GmbH
 Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany. | Biotechnology | Chairman Chief Executive Officer | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Director/Board Member | |
Solaris Pharma Corp.
 Solaris Pharma Corp. Pharmaceuticals: MajorHealth Technology Solaris Pharma Corp. engages in the development and commercialization of specialty pharmaceutical products. Its topical dosage forms that are developed at its facility include ointments, gels, creams, lotions, solutions, sprays, and foams. The company was founded by Lakshmi Raghavan in 2014 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Indigo Diabetes NV
 Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member Director/Board Member | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Founder Chairman | |
SWB Holding GmbH (Bayern)
 SWB Holding GmbH (Bayern) Financial ConglomeratesFinance SWB Holding GmbH is a German Munich-based company that was founded in 2013. The private company provides investment services. Thomas Peter Maier has been the CEO of the company since 2018. | Financial Conglomerates | Chief Executive Officer | |
A&T Grundstück 1 GmbH
 A&T Grundstück 1 GmbH Real Estate DevelopmentFinance A & T Grundstück 1 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Thomas Maier, Sebastian Breyer, Helmut Jeggle. The company engages in buying and selling of commercial premises & non-residential buildings. | Real Estate Development | Chief Executive Officer | |
A&T Grundstück 2 GmbH
 A&T Grundstück 2 GmbH Real Estate DevelopmentFinance A & T Grundstück 2 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Sebastian Breyer, Helmut Jeggle, Thomas Peter Maier. The company buys and sells land, buildings, and apartments. | Real Estate Development | Chief Executive Officer | |
Palais Berlin 1 GmbH
 Palais Berlin 1 GmbH Real Estate DevelopmentFinance Palais Berlin 1 GmbH is a German company that specializes in the buying and selling of land, buildings, and flats. The private company is based in Munich, Germany. The CEOs of the company are Thomas Maier, Helmut Jeggle, Sebastian Breyer. | Real Estate Development | Chief Executive Officer | |
ATHOS KG
 ATHOS KG Financial ConglomeratesFinance ATHOS KG is an investment holding German company founded in 2019. The company is based in Holzkirchen, Germany. | Financial Conglomerates | Chief Executive Officer | |
| Verinos Pharmaceuticals GmbH | Director/Board Member Director/Board Member | ||
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Objektgesellschaft Berlin Passauer Straße 5-7 mbH
 Objektgesellschaft Berlin Passauer Straße 5-7 mbH Real Estate DevelopmentFinance Objektgesellschaft Berlin Passauer Straße 5-7 mbH is a company based in Munich, Germany. Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft Berlin Passauer Straße 5-7 mbH rents, leases, and owns land, buildings, and apartments. The German company was founded in 1997 and the CEOs are Helmut Jeggle and Thomas Peter Maier. | Real Estate Development | Chief Executive Officer |
Statistics
International
| Germany | 34 |
| United States | 7 |
| United Kingdom | 5 |
| Belgium | 4 |
| Netherlands | 2 |
Sectoral
| Health Technology | 23 |
| Finance | 14 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 245 |
| Corporate Officer/Principal | 133 |
| Chief Executive Officer | 111 |
| Chairman | 64 |
| Independent Dir/Board Member | 39 |
Most connected contacts
| Insiders | |
|---|---|
| Helmut Jeggle | 47 |
| Tamar Howson | 41 |
| Christof Hettich | 40 |
| Jörg Neermann | 34 |
| Heiko Roman Michael Fischer | 30 |
| Thomas Werner | 25 |
| Vincent Ossipow | 22 |
| Manfred Rüdiger | 22 |
| Jason Loveridge | 20 |
| Günter Frankenne | 19 |
| Philip Grosse | 18 |
| Irina Antonijevic | 17 |
| Tamara Favorito | 17 |
| Clemens M. Doppler | 17 |
| Helga Rübsamen-Schaeff | 16 |
- Stock Market
- Insiders
- Daniel Vitt
- Company connections
